|
Muro-Perez J, Muro-Perez M, Galian JA, Perez-Lopez N, Legaz I, Muro M. Donor-Derived Cell-Free DNA in Acute and Chronic Rejection of Solid Allograft Transplantation. Results Probl Cell Differ. 2026;77:151-164. doi: 10.1007/978-3-032-07686-1_7. PubMed PMID: 41479025.
AÑO: 2026
|
41479025
|
Moya-Quiles MR, Muro M. Identification of Two New HLA-C Alleles: HLA-C*06:02:01:107 and -C*07:01:01:148. HLA. 2026 Jan;107(1):e70541. doi: 10.1111/tan.70541. PubMed PMID: 41466486.
AÑO: 2026; IF: 4.1
|
|
Martinez-Alcaraz M, Gil M, Llorente S, Botella C, Galian JA, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria MJ, Hita A, Moya MR, Martinez-Banaclocha H, Muro-Perez M, Muro J, Minguela A, Legaz I, Muro M. Evaluation of desensitizing therapies for donor-specific antibodies in confirmed humoral allograft rejection in kidney transplantation: Experience of a center for 10 years. Transpl Immunol. 2026 Feb 13:102363. doi: 10.1016/j.trim.2026.102363. Online ahead of print. PubMed PMID: 41692073.
AÑO: 2026; IF: 1.4
|
|
Alfaro R, Gonzalez-Martinez G, Muro-Perez M, Galian JA, Martinez-Banaclocha H, Fernandez-Gonzalez M, Botella C, Moya-Quiles MR, Muro J, Llorente S, Muro M. Advanced in silico drug design strategies for mitigating transplant rejection: a status update. Expert Opin Drug Discov. 2026 Mar 10. doi: 10.1080/17460441.2026.2642965. Online ahead of print. PubMed PMID: 41804282.
AÑO: 2026; IF: 4.9
|
|
Moya-Quiles MR, Muro M. Characterisation of the Novel HLA-C*05:311 Allele by Next-Generation Sequencing. HLA. 2025 Dec;106(6):e70508. doi: 10.1111/tan.70508. PubMed PMID: 41371629.
AÑO: 2025; IF: 4.1
|